Y-Intercept (HK)’s Vera Therapeutics VERA Stock Holding History

Y-Intercept (HK)’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$660K	Buy	15,391 +3,721	+32%	+$139K	0.01%	1218
2026 Q1	$469K	Sell	11,670 -17,772	-60%	-$766K	0.01%	1269
2025 Q4	$1.49M	Sell	29,442 -37,751	-56%	-$1.34M	0.03%	770
2025 Q3	$1.95M	Buy	+67,193	New	+$1.55M	0.05%	621
2025 Q2	–	Sell	-12,212	Closed	-$293K	–	2046
2025 Q1	$293K	Buy	+12,212	New	+$392K	0.02%	916
2024 Q4	–	Sell	-30,911	Closed	-$1.37M	–	1688
2024 Q3	$1.37M	Buy	30,911 +22,843	+283%	+$867K	0.08%	314
2024 Q2	$292K	Sell	8,068 -6,270	-44%	-$249K	0.02%	1040
2024 Q1	$618K	Buy	+14,338	New	+$511K	0.05%	605

Other funds holding VERA

EOJOAM

E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

AAM

AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return

SOAM

SBI Okasan Asset Management Tokyo, Japan $3.04B AUM

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

GWMR

GC Wealth Management RIA Cambridge, Massachusetts $1.73B AUM 16.14% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Y-Intercept (HK)'s VERA Position: Q2 2026 in Review

Y-Intercept (HK) increased its Vera Therapeutics (VERA) stake by 32% in Q2 2026, buying an estimated $139K and bringing the position to 15,391 shares worth $660K. The position accounts for 0.01% of the portfolio, ranked #1218.

Y-Intercept (HK) first reported a position in VERA in Q1 2024 and has held it in 8 quarters since. The position peaked at $1.95M in Q3 2025. 19 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

Y-Intercept (HK) held 15,391 shares of Vera Therapeutics worth $660K as of Q2 2026.
Y-Intercept (HK) bought 3,721 Vera Therapeutics shares in Q2 2026, an estimated $139K.
Vera Therapeutics made up 0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1218 holding.
Y-Intercept (HK) first reported a position in Vera Therapeutics in Q1 2024 and has held it in 8 quarters since.
Y-Intercept (HK)'s Vera Therapeutics position peaked at $1.95M in Q3 2025.
19 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.